news
Supplement industry pushes for 'decentralized' clinical trials
A new article in SupplySide Supplement Journal makes the case for "decentralized" or hybrid clinical trials for supplements. This model would allow participants to join studies from home, making research more accessible and potentially speeding up how quickly new products can make claims.
A new article in SupplySide Supplement Journal makes the case for "decentralized" or hybrid clinical trials for supplements. This model would allow participants to join studies from home, making research more accessible and potentially speeding up how quickly new products can make claims.
The architecture take
Okay, so the supplement industry wants to make clinical trials easier to run and recruit for. The idea is to let people participate from their couch instead of a lab. Translation: less friction means more studies can get off the ground, fast. This could be great for getting more data on supplement efficacy, moving beyond just 'anecdotal evidence' or 'trust us, bro' claims.
But here's the quiet part: When you decentralize, you risk diluting the rigor. The article spins it as balancing 'participant convenience with rigorous oversight,' which sounds nice on paper, but history says corners get cut when things get too convenient. Watch for what this does to the actual 'evidence credibility' part. Will we get more studies, or just more studies that look like studies? The industry wins with more studies, regardless, because it gives them more marketing fodder. For you, the consumer, it means you'll need to squint even harder at those 'clinically proven' labels. Don't let the comfy couch override science.